Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ribhi M. Shawar"'
Autor:
Ligia A. Pinto, Ribhi M. Shawar, Brendan O’Leary, Troy J. Kemp, James Cherry, Natalie Thornburg, Cheryl N. Miller, Pamela S. Gallagher, Timothy Stenzel, Brittany Schuck, S. Michele Owen, Marina Kondratovich, Panayampalli S. Satheshkumar, Amy Schuh, Sandra Lester, M. Cristina Cassetti, Norman E. Sharpless, Steven Gitterman, Douglas R. Lowy
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 1 (2022)
ABSTRACT The emergence of SARS-CoV-2 created a crucial need for serology assays to detect anti-SARS-CoV-2 antibodies, which led to many serology assays entering the market. A trans-government collaboration was created in April 2020 to independently e
Externí odkaz:
https://doaj.org/article/fd1d888a005e451da19462a26970c706
Autor:
Shawn R. Lockhart, Richard B. Thomson, Ribhi M. Shawar, Esther Babady, Sandra S. Richter, Ana María Cárdenas, Margie Morgan, Marcelo Galas, Kevin Alby, Mark G. Papich, Nicole Hubbard, Audrey N. Schuetz, Karissa Culbreath, German Esparza, Brian V. Lubbers, Jean B. Patel, Susan E. Sharp
Publikováno v:
J Clin Microbiol
On behalf of the Clinical and Laboratory Standards Institute (CLSI), the Expert Panel on Microbiology would like to respond to the recent commentary by Kirby and colleagues voicing concerns related to verification of commercial antimicrobial suscepti
Autor:
Allison C Brown, Ribhi M. Shawar, Patricia Conville, Jean B. Patel, Joseph D. Lutgring, Faiza H. Benahmed, María-José Machado
The FDA-CDC Antimicrobial Resistance Isolate Bank was created in July 2015 as a publicly available resource to combat antimicrobial resistance. It is a curated repository of bacterial isolates with an assortment of clinically important resistance mec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47c107e569beb2a4ec2434ac0a6245a7
https://europepmc.org/articles/PMC5786719/
https://europepmc.org/articles/PMC5786719/
Autor:
Stacey L. Walsh, Monique Twynholm, Elizabeth Thomas, F. Patrick O'Hara, Julie A. Becker, Stephanie Van Horn, Heather Amrine-Madsen, Richard V. Goering, Ribhi M. Shawar, Nicole Scangarella, Marybeth Dalessandro, Linda A. Miller, Joshua West
Publikováno v:
Journal of Clinical Microbiology. 46:2842-2847
Determining the genetic characteristics of Staphylococcus aureus is important for better understanding of the global and dynamic epidemiology of this organism as we witness the emergence and spread of virulent and antibiotic-resistant clones. We geno
Autor:
Jenny R. Stapp, Carla R. Clausen, Jane L. Burns, S. K. Tanaka, Ribhi M. Shawar, Richard L. Garber, David Macleod
Publikováno v:
Antimicrobial Agents and Chemotherapy. 43:2877-2880
The in vitro activity of tobramycin was compared with those of six other antimicrobial agents against 1,240 Pseudomonas aeruginosa isolates collected from 508 patients with cystic fibrosis during pretreatment visits as part of the phase III clinical
Autor:
Ribhi M. Shawar, Alice S. Weissfeld
The Food and Drug Administration (FDA) is charged with protecting the public health by ensuring the safety and efficacy of human and veterinary drugs, biological products, and medical devices. It is also charged with ensuring the safety of foods, cos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b2ed29ef854c4834e4f0dee3207fc5f
https://europepmc.org/articles/PMC3185846/
https://europepmc.org/articles/PMC3185846/
Publikováno v:
Journal of Clinical Microbiology. 31:61-65
insertion sequence IS6110 wasamplified. Thedetection limit ofthePCRassay forcultured mycobacteria was50cells perreaction byethidium bromide-stained agarose gelelectrophoresis and5cells perreaction byhybridization withan oligonucleotide probeconjugate
Publikováno v:
Clinical Infectious Diseases. 15:938-940
Agrobacterium species have been previously implicated in the development of clinical disease. We report what we believe to be the first case of ascites caused by Agrobacterium tumefaciens in a cirrhotic patient. Since the correct diagnosis was made o
Autor:
Betty B. Lin, Joy E. Dirks, George H. Miller, David Macleod, Ribhi M. Shawar, Laura E. Nelson, Luann G. Lockwood, Richard L. Garber, Jane L. Burns
Publikováno v:
The Journal of infectious diseases. 181(3)
Aminoglycoside-resistance mechanisms were characterized in Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients during a recent clinical trial of inhaled tobramycin. Impermeability, in which bacteria have reduced susceptibility to all a
Publikováno v:
Clinical Microbiology Newsletter. 13:142-144